MEBENDAZOLE Patent for Treatment of CANCER

Mebendazole is sometimes called an “animal dewormer” like Ivermectin and Fenbendazole.

On Sep.7, 2021, Johns Hopkins University in Baltimore, MD secured a patent for MEBENDAZOLE for this use:

1. Repurposed for Glioblastoma Therapy

(as an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations)

2. Mebendazole may also be used for therapy of other cancers, as well as a chemo-preventative agent.

Patent No. US 11,110,079 B2
Date of Patent: Sep.7, 2021

The title of the patent: “Mebendazole Polymorph for Treatment and Prevention of Tumors”

Applicant: Johns Hopkins University
Inventors: Gregory Riggins, et al

I will let this sink in.

This is what I have been working with for the past 2 years, in the largest Ivermectin Cancer Project in the world. 9000+ Cancer patients.

You have never seen this patent in the news.

You have never seen any Oncologist talk about this patent.

Yet, this is a game changer for Glioblastoma Cancer patients.